Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LSV1 GTx
- Development stage
- Preclinical
- Lead developer
- Adverum Biotechnologies
- Modality
- Gene Therapies
- Administration
- Intravitreal
01
Overview
LSV1 GTx refers to a series of undisclosed preclinical gene therapy programs developed by Adverum Biotechnologies. These programs utilize the company's proprietary LSV1 platform, which is a next-generation viral vector delivery system (likely based on adeno-associated virus, or AAV) designed to improve the efficiency and safety of gene delivery. While the specific therapeutic targets and disease indications for these programs have not been publicly revealed, they represent Adverum's ongoing efforts to expand its pipeline beyond its lead candidates in ophthalmology. The LSV1 platform is part of Adverum's vector discovery engine, aimed at developing long-lasting treatments for ocular and other chronic diseases through optimized vector engineering.
- Other names
- LSV1 platform programsLSV-1 platform programsLSV 1 platform programs
Beyond the preview
Go deeper on LSV1 GTx.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LSV1 GTx.